Cormorant Asset Management’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.6M Buy
+5,500,000
New +$22.8M 1.79% 19

Other funds holding IRD

Cormorant Asset Management's IRD Position: Q3 2026 in Review

Cormorant Asset Management opened a new position in Opus Genetics (IRD) in Q3 2026: 5,500,000 shares worth $26.6M. The stake represents 1.79% of the portfolio and ranks #19 among its holdings.

97 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Cormorant Asset Management held 5,500,000 shares of Opus Genetics worth $26.6M as of Q3 2026.
  • Opus Genetics was a new Cormorant Asset Management position in Q3 2026.
  • Opus Genetics made up 1.79% of Cormorant Asset Management's portfolio in Q3 2026, its #19 holding.
  • 97 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.